IP Library › Granted Patent US 10,792,042
Granted Patent B2
US 10,792,042 · App. 14/597,532 · Granted Oct 6, 2020

Circular staplers having resorbable microneedles containing active agents

Inventors: John P. Matonick (Warren, NJ); Robert J. Tannhauser (Bridgewater, NJ); Leo B. Kriksunov (Ithaca, NY)
Assignee: Ethicon, Inc.
A61B17/1155A61B17/07292A61B17/1114A61K9/0021A61M37/0015A61B17/072A61B2017/00004A61B2017/00893A61B2017/0647A61B2017/07257A61B2017/07271A61B2090/037A61M2037/0046A61M2037/0061A61M2205/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,792,042
App. No.
14/597,532
Granted
Oct 6, 2020
Kind
B2
Abstract

The present invention is directed to circular surgical staplers for anastomotic joining of tissue comprising a stapling head connected to an opposing anvil, said stapling head containing a plurality of deployable staples in concentric arrays; a plurality of resorbable medicant-releasing microneedles, the microneedles comprising elongated rods having a sharp tissue-penetrating distal end and a proximal end; with the microneedles releasably disposed on or within the stapling head or the anvil. The present invention is also directed to methods of use of such stapler devices.

Claims (12)

1. A circular surgical stapler for anastomotic joining of tissue comprising:

a) a stapling head connected to an opposing anvil, said stapling head containing a plurality of deployable staples in concentric arrays;

b) a plurality of solid, barbed, resorbable medicant-releasing microneedles, said microneedles comprising elongated rods having a sharp tissue-penetrating distal end and a proximal end; said microneedles releasably and detachably disposed on or within the stapling head or the anvil;

wherein said microneedles are configured to break off and detach and to be left in the tissue layers after joining of the tissue layers;

and

wherein said medicant is impregnated into or distributed within a polymeric material comprising said microneedle, is coated onto said microneedle, or is a discrete elongated insert within said microneedle.

2. The stapler of claim 1 , wherein the microneedles are disposed on a tissue-facing surface of the stapling head on a periphery of the stapling head and outside of the concentric arrays of the deployable staples.

3. The stapler of claim 2 , wherein said microneedles further comprise a barb at the distal end thereof and wherein said microneedles are substantially perpendicular to the tissue-facing surface.

4. The stapler of claim 2 , wherein said microneedles are releasably supported by an attachment strip disposed on the tissue-facing surface.

5. The stapler of claim 2 , wherein the stapling head comprises at least 10 microneedles and wherein said microneedles are from 50 microns to about 1000 microns in diameter and from about 100 microns to about 2500 microns long.

6. The stapler of claim 1 , wherein said medicant comprises a drug, an enzyme, a growth factor, an anti-inflammatory agent, a vasodilating agent, a peptide, a protein, a nutrient, an excipient, a cell, or combinations thereof.

7. The stapler of claim 1 , wherein the medicant is released over a period of from about 2 hours to about 4 weeks.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2015
From: MATONICK, JOHN P.; TANNHAUSER, ROBERT J.; KRIKSUNOV, LEO B.
To: ETHICON, INC.
Reel/Frame 036969/0502 →
Continuity (1)
Related Publication 20160206865A1 · Jul 21, 2016
Cited By (1)
US 12,274,437